What molecular mechanisms underlie the RNA-dependent TDP-43-ATXN2 interaction and its role in ALS pathogenesis?

The abstract establishes that ATXN2 and TDP-43 form an RNA-dependent complex that modifies TDP-43 toxicity, but the specific molecular mechanisms are not explained. Understanding this interaction is critical for developing targeted therapeutics for ALS and other TDP-43 proteinopathies.

Gap type: unexplained_observation Source paper: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. (None, None, PMID:20740007)

Resolved when an evidence artifact characterizes the RNA-dependent TDP-43-ATXN2 interaction mechanism with one of: (1) crosslinking immunoprecipitation sequencing (CLIP-seq) identifying >=20 ATXN2-bound RNAs in motor neurons that also recruit TDP-43, with functional annotation of these targets as RNAs encoding synaptic proteins or RNA granule components (FDR < 0.05, n >= 3 replicates); (2) biophysical characterization (surface plasmon resonance or isothermal titration calorimetry) defining the TDP-43 RRM domain-ATXN2 LSm domain binding affinity (KD <= 100 nM) and the requirement for the ATXN2 polyA-binding motif in mediating the interaction; (3) cellular validation in iPSC-derived motor neurons using ASO-mediated ATXN2 knock-down or CRISPRi of specific ATXN2 isoforms showing >=50% reduction in TDP-43 aggregation markers (phosphorylated TDP-43, insolubility) without affecting normal TDP-43 splicing of N让它 targets. The artifact must include quantitative thresholds and link the mechanism to ALS pathogenesis.

Resolved by hypothesis h-ccc05373: p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance. Score: 0.879. Supporting PMIDs: 39817908, NCT05869669, 39817908, NCT05869669, 39817908.